Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian equity markets continue to slide
Fri, 8 Nov 01:30 pm

Backed by persistent selling activity Indian markets continued to trade weak during the post noon trading session. Most of the sectoral indices are trading in red with consumer durables and banking stocks leading the pack of losers. While, stocks from capital goods and healthcare sectors are among the leading gainers.

BSE-Sensex is down by 123 points and NSE-Nifty is trading down by 38 points. While BSE Mid Cap is trading down by 0.19%, BSE Small Cap index is trading down by 0.64%. The rupee is trading at 62.24 to the US dollar.

Most of the Indian pharma stocks are trading in green, with Aurobindo pharma and Dishman Ltd being the leading gainers. Aurobindo has declared its September quarter results. Net sales grew by 27.7% YoY, led by growth in both formulations and API (Active pharmaceutical ingredients) segment. Among the export formulations US witnessed robust growth of 72% YoY. However ARVs (Anti retroviral) sales declined by 7.6% YoY. On the margins front, company's EBITDA margins improved by 6.4% to 21.9%, leading to EBITDA growth of 80% YoY for the said period. Lower sales of low margin ARV also helped the margin improvement. However on the bottom line, the growth was just 5% YoY. This was largely due to forex loss incurred during the quarter vs forex gain in 2QFY13. Aurobindo is currently trading up by 9.5%

Majority of the energy stocks are trading in the red with Chennai Petroleum and Jindal Drill being the major losers. Only Hindustan Petroleum Corporation LTd (HPCL) is trading positive. As per a leading financial daily, the de-regulation of bulk diesel prices has opened up this segment for participation by the private refinery companies. Therefore companies like Reliance Industries and Essar Oil are bidding to supply high-speed diesel to the country's single largest consumer, the Indian Railways. While Reliance Industries has bid for 11 locations, Essar Oil has bid for only one location in Gujarat. Presently public sector oil marketing companies (OMCs), Indian Oil Corp Ltd (IOCL), Bharat Petroleum Corporation Ltd (BPCL) and HPCL offer a discount of 52 paise per litre over bulk diesel rate of Rs 63 a litre. Reportedly OMC's are not keen to extend discounts any longer after diesel rates have become market-linked and are around Rs 9-10 higher than the subsidized rate.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets continue to slide". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.